Clostridium septicum myonecrosis in a pediatric patient with a self-reported penicillin allergy

Parmvir Parmar1,2, Joshua Feder3, Anne Pham-Huy4

  • 1Division of Infectious Diseases, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Insights

Clostridium septicum myonecrosis is rare in children. This case highlights prompt surgical debridement, penicillin therapy, and penicillin allergy de-labeling for successful treatment in a pediatric lymphoma patient.

Area of Science:

  • Infectious Diseases
  • Pediatric Oncology
  • Surgical Infections

Background:

  • Clostridium septicum infections are rare in pediatric patients, often linked to malignancy.
  • Standard treatment for C. septicum myonecrosis involves surgical debridement and high-dose penicillin.
  • Management and optimal therapy duration for penicillin-intolerant patients remain unclear.

Observation:

  • A 14-year-old with Burkitt's lymphoma and suspected penicillin allergy developed spontaneous myonecrosis.
  • Initial treatment included ceftazidime, metronidazole, and debridement.
  • A delayed inflammatory response correlated with neutrophil recovery during severe neutropenia.

Findings:

  • The patient ultimately received 3 weeks of intravenous penicillin after a graded challenge, leading to cure.
  • Clostridium septicum myonecrosis can present insidiously and progress rapidly.
  • Repeat surgical "second-look" procedures are crucial for effective management.

Implications:

  • This case underscores the importance of de-labeling penicillin allergies in clinical practice.
  • Vigilance and prompt intervention are essential for managing rare pediatric C. septicum infections.
  • Understanding atypical presentations and treatment responses in immunocompromised children is vital.

Related Concept Videos